Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Gut microbiota and macrophage crosstalk: implications for colitis-associated colorectal cancer

Lyu W., Zhang Z., Liu L., Sun Y., Wang B., Zhou C.

Narrative Review on Chronic Inflammation, Autoimmune Research, published in Front Cell Infect Microbiol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Cell Infect Microbiol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41816358
PMCID
PMC12971970
DOI
10.3389/fcimb.2026.1778244
Citations
3

Abstract (original English)

Colitis-associated colorectal cancer (CAC) is one of the most severe complications associated with inflammatory bowel disease (IBD). Within the global landscape of cancer epidemiology, colorectal cancer (CRC) ranks among the leading malignancies in terms of both incidence and mortality. CAC, which arises in the context of IBD-including Crohn's disease and ulcerative colitis-represents a distinct subtype of CRC that is closely linked to chronic intestinal inflammation. The pathogenesis of CAC is driven by the complex intestinal microenvironment, characterized by dynamic interactions among immune cells, epithelial cells, and the gut microbiota. In this setting, macrophages serve as central regulators of intestinal immunity and exhibit significant plasticity in response to microbial stimuli. Under homeostatic conditions, macrophages contribute to tissue integrity through phagocytic activity and the production of anti-inflammatory mediators. However, during prolonged inflammation, persistent exposure to a dysbiotic microbiota induces functional reprogramming of macrophages toward a pro-tumorigenic phenotype. Pathogenic bacteria enriched in CAC tissues-such as Fusobacterium nucleatum and Escherichia coli -secrete virulence factors that promote macrophage polarization into an immunosuppressive M2-like state, thereby facilitating the establishment of a tumor-permissive microenvironmen

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
MacrophagesAnimalsHumansColorectal NeoplasmsInflammatory Bowel DiseasesTumor MicroenvironmentDysbiosisGastrointestinal MicrobiomeColitis-Associated Neoplasms

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research